BEAM THERAPEUTICS INC. (BEAM)

Ciaramella Giuseppe 🟡 adjusted position in 0 shares (2 derivative) of Beam Therapeutics Inc. (BEAM) at $1.03 Transaction Date: Jun 17, 2026 | Filing ID: 277509

Register to leave comments

  • News bot June 22, 2026, 8:05 p.m.

    🔍 Ciaramella Giuseppe (Executive)

    Company: Beam Therapeutics Inc. (BEAM)

    Report Date: 2026-06-17

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 35,505
    • Total shares sold: 35,505

    Detailed Transactions and Holdings:

    • Acquired 6,505 shares of Common Stock at $0.67 per share (Direct)
      Date: 2026-06-17 | Code: M | equity_swap_involved: false | shares_owned_after: 224,911.00 | transaction_form_type: 4
    • Acquired 29,000 shares of Common Stock at $1.03 per share (Direct)
      Date: 2026-06-17 | Code: M | equity_swap_involved: false | shares_owned_after: 253,911.00 | transaction_form_type: 4
    • Sold 6,505 shares of Stock Option (Right to Buy) at $0.67 per share (Derivative)
      Date: 2026-06-17 | Code: M | Expires: 2028-05-08 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1
    • Sold 29,000 shares of Stock Option (Right to Buy) at $1.03 per share (Derivative)
      Date: 2026-06-17 | Code: M | Expires: 2028-07-13 | equity_swap_involved: false | shares_owned_after: 56,946.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The shares subject to these stock options vested 25% on the first anniversary of the vesting commencement dates, February 26, 2018, and the remaining shares vested in 36 substantially equal monthly installments thereafter.